Breast Milk Sugars Tied to Fewer Resistant Gut Genes

A baby born today can already be carrying antibiotic-resistance genes in its gut bacteria within the first month of life, even if it has never been given an antibiotic itself. That is the starting point of a new study that also found something more useful: specific sugars naturally present in a mother's breast milk are linked to a lighter load of those resistance genes, and the effect shows up most clearly in babies born by C-section (cesarean section). For anyone already digging into how a baby's start in life shapes their gut health, this is one of the more concrete pieces of evidence yet that the exact composition of breast milk, not just whether a baby is breastfed at all, matters.

Key takeaways

• Two milk sugars, 2'-fucosyllactose and 6'-sialyllactose, were linked to lower levels of specific antibiotic-resistance genes in one-month-old infants' guts, across two independent groups of families.
• Babies born by C-section carried a more diverse set of resistance genes than vaginally born babies, but that gap narrowed in babies fed by mothers who naturally produce more of these sugars.
• This is a correlational study; it shows a link, not proof the sugars themselves cause fewer resistant bacteria, and the two study groups did not agree on every detail.

Newborns Already Carry Resistance Genes Before Any Antibiotic

Researchers led by Anna Samarra and Maria Carmen Collado at Spain's Institute of Agrochemistry and Food Technology (IATA-CSIC), working with collaborators including Lars Bode at UC San Diego's Human Milk Institute, sequenced stool samples from 57 one-month-old infants in the Spanish MAMI cohort. Only one infant in the group had ever been given antibiotics directly, yet the team still found 208 distinct antibiotic-resistance genes (ARGs, the genetic instructions bacteria use to survive a drug) spread across the group, covering resistance to 16 different antibiotic classes. Genes resisting tetracyclines and beta-lactams (the drug family that includes penicillin) were the most common; one tetracycline-resistance gene, tet(S/M), turned up in 84.2% of the babies, and a macrolide-resistance gene, msr(D), appeared in more than 90%. Even beneficial bacteria carried resistance genes: Bifidobacterium longum and Bifidobacterium breve, both prized members of a healthy infant gut, each carried multiple ARGs, though Staphylococcus aureus was the single largest contributor, carrying 33 of the resistance genes detected.

Delivery Mode and Breastfeeding Both Reshape the Resistance-Gene Mix

The study, published September 1, 2026 in Cell Reports Medicine, found that two factors tracked most closely with how many resistance genes a baby carried: exclusive breastfeeding and mode of delivery. Exclusive breastfeeding explained the largest share of the variation in resistance-gene composition of any factor tested, and exclusively breastfed infants had a measurably different, generally lighter resistance-gene profile than infants who weren't. Delivery mode mattered too: infants born by C-section carried a more diverse set of resistance genes than those born vaginally, a pattern that echoes older research linking C-section birth to slower gut colonization in the first weeks of life. Among vaginally born infants, missing out on exclusive breastfeeding was linked to a heavier resistance-gene load. Antibiotic resistance in young children is already considered a growing public health concern, which is part of why researchers want to understand how it takes hold this early.

Two Milk Sugars, Two Cohorts, One Consistent Signal

To pin down what in breast milk was doing the work, the team sequenced 50 mothers' milk samples and chemically profiled the human milk oligosaccharides (HMOs, complex sugar molecules unique to milk that a baby cannot digest but gut bacteria can) in 40 of them. Milk composition depends heavily on "secretor status," a genetically determined trait, tied to the FUT2 gene, that roughly 80% of women carry and that changes which HMOs show up in their milk. Secretor mothers' milk contained nearly 50% more total HMO content, a median of 12.19 mg/mL versus 8.24 mg/mL in non-secretor mothers' milk, and lower levels of certain resistance genes. Two specific sugars in that mix, 2'-fucosyllactose (2'FL) and 6'-sialyllactose (6'SL), were negatively correlated with distinct classes of resistance genes: the more of these sugars in a mother's milk, the fewer of those particular resistance genes turned up in her baby's gut, a pattern that lines up with earlier cohort work tying specific HMOs to shifts in infant gut bacteria. The team then checked the broader delivery-mode-by-secretor-status pattern in a second, independent group, the Dutch Lifelines NEXT cohort of 199 exclusively breastfed infants (150 born to secretor mothers, 49 to non-secretors), giving the finding more weight than a single-cohort result would carry.

What This Means If You're Breastfeeding After a C-Section

For parents currently breastfeeding, especially after a C-section, the practical read is not that anyone should change how they feed a baby: the study analyzed breast milk as it naturally occurs and did not test any supplement or intervention. What it adds is another documented reason exclusive breastfeeding is associated with a distinct gut profile, alongside its established links to lower infection risk in early childhood, a period when antibiotic resistance is a rising concern. In the original Spanish cohort, secretor mothers' milk appeared to blunt the usual C-section-associated increase in resistance genes: among babies fed by secretor mothers, resistance-gene diversity didn't differ significantly by delivery mode, while among babies fed by non-secretor mothers, C-section birth was linked to a distinct resistome. Secretor status isn't something a parent can easily test for or change today, so this isn't yet a "do this" finding, more a piece of the explanation for why outcomes can vary between families even when everyone is breastfeeding.

The Two Cohorts Didn't Point the Same Direction Every Time

The clearest limitation is that this is a correlational study: it can show certain milk sugars track with fewer resistance genes without proving the sugars themselves are the cause. The Spanish cohort's non-secretor, exclusively breastfed subgroup was also small, just 9 infants, which limits how confidently that specific comparison can be read. The two cohorts didn't fully agree on direction either: in the Spanish group, delivery mode changed the resistome only among non-secretor-fed babies, but in the larger Dutch validation cohort, delivery mode significantly changed resistance-gene counts in secretor-fed babies too, and in the opposite direction (a median of 22.4 genes after C-section versus 17.6 after vaginal birth). The researchers also found that which antibiotic classes were most affected differed between the two cohorts, a sign that geography, diet, or local bacterial exposure likely shape the outcome alongside milk chemistry.

Where This Research Goes Next

The team followed the Spanish infants through 6 and 12 months of age, and a natural next step for the field is tracking whether these early resistome differences persist, shrink, or resolve as children are weaned and eventually exposed to their first antibiotic course. Because 2'FL and 6'SL already exist as manufactured ingredients added to some infant formulas, a longer-term open question is whether supplementing formula with these specific sugars could narrow the resistome gap between breastfed and formula-fed infants. This study did not test formula, so it offers no evidence either way yet.

Common Questions

What is the "gut resistome"? It's the full collection of antibiotic-resistance genes carried by the bacteria living in the gut, whether or not that person has ever taken an antibiotic themselves.

Does this mean C-section babies are unhealthy? No. The study found C-section birth was linked to a more diverse mix of resistance genes, not to illness; most of these genes sit quietly in gut bacteria without causing an infection.

Can I get tested for secretor status? Secretor status can be determined with a saliva or blood-based genetic test for the FUT2 gene, but it isn't a standard part of prenatal or postpartum care, and this study does not suggest testing is currently useful for parents.

Should I look for infant formula with added 2'-FL? Some formulas already include 2'-fucosyllactose as an additive, but this study did not test formula, so it does not show that added HMOs in formula reduce a baby's resistance-gene load the way natural breast milk did here.

References

1. Anna Samarra, Alejandro J. Alcañiz, Narciso M. Quijada, et al. (2026). Maternal secretor status and human milk oligosaccharides influence the infant gut resistome. Cell Reports Medicine. https://doi.org/10.1016/j.xcrm.2026.103007
2. UC San Diego Human Milk Institute. hmi.ucsd.edu. https://hmi.ucsd.edu/about-us/history-drawer.html
3. CDC: Antibiotic Resistance Threats Report. cdc.gov. https://www.cdc.gov/antimicrobial-resistance/data-research/threats/index.html
4. David Barnett (2023). Human milk oligosaccharides, antimicrobial drugs, and the gut microbiota of term neonates: observations from the KOALA birth cohort study. https://doi.org/10.52843/cassyni.q5p01w
5. The Growing Threat of Antibiotic Resistance in Children. NIH. https://pmc.ncbi.nlm.nih.gov/articles/PMC5927609/